For the Inventor, By the Inventor

Enter assignee name

Smyrna, GA, United States of America

Geovax, Inc.

USPTO Granted Patents = 14

% Expired Patents = 7.1

EPO Patents = 1

Trademarks = 3

Forward Citations = 13

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Arban Domi (12 out of 13 patents)

Farshad Guirakhoo (9 out of 10 patents)

Harriet L Robinson (8 out of 19 patents)

4. Nathanael Paul McCurley (8 out of 9 patents)

5. Michael Salant Hellerstein (6 out of 6 patents)

6. Rahul Basu (1 out of 2 patents)

7. Ming Luo (1 out of 4 patents)

8. Mary Jo Hauser (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12577589 - VACCINES AND USES THEREOF TO INDUCE AN IMMUNE RESPONSE TO SARS-COV2 (2026-03-17),

2. 12370249 - Replication-deficient modified vaccinia ankara (MVA) expressing marburg virus glycoprotein (GP) and matrix protein (VP40) (2025-07-29),

3. 12329808 - Compositions and methods for generating an immune response to treat or prevent malaria (2025-06-17),

4. 12247214 - Vaccinia viral vectors encoding chimeric virus like particles (2025-03-11),

5. 11897919 - Multivalent HIV vaccine boost compositions and methods of use (2024-02-13),

6. 11896657 - Replication-deficient modified vaccinia Ankara (MVA) expressingglycoprotein (GP) and matrix protein (VP40) (2024-02-13),

7. 11857611 - Compositions and methods for generating an immune response to treat or prevent malaria (2024-01-02),

8. 11701418 - Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40) (2023-07-18),

9. 11638750 - Methods for generating a Zikv immune response utilizing a recombinant modified vaccina Ankara vector encoding the NS1 protein (2023-05-02),

10. 11413341 - Vaccinia viral vectors encoding chimeric virus like particles (2022-08-16),

11. 11311612 - Compositions and methods for generating an immune response to treat or prevent malaria (2022-04-26),

12. 11278607 - Compositions and methods for generating an immune response to a tumor associated antigen (2022-03-22),

13. 11098086 - Multivalent HIV vaccine boost compositions and methods of use (2021-08-24),

14. 11052148 - Compositions and methods for generating an immune response to hepatitis B virus (2021-07-06),

GeoVax, Inc. is a clinical-stage biotechnology company developing innovative human vaccines for infectious diseases through its novel Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) platform technology. The company's primary focus is on developing vaccines for HIV, Zika virus, and hemorrhagic fever viruses. GeoVax's vaccines are designed to elicit immune responses that provide protection against a wide range of disease-causing pathogens. With a strong pipeline of vaccine candidates and a commitment to improving global health, GeoVax is leading the way in vaccine development and disease prevention.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

14 Patents

#5 in Smyrna, GA

#443 in Georgia

#22,289 in US

#42,168 in the World

Smyrna, GA, United States of America

Geovax, Inc.

Forward Citations = 13

8 inventors:

Arban Domi (12 out of 13 patents)

Farshad Guirakhoo (9 out of 10 patents)

Harriet L Robinson (8 out of 19 patents)

4. Nathanael Paul McCurley (8 out of 9 patents)

5. Michael Salant Hellerstein (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…